Factors Associated With Systemic Immune Activation Indices in a Global Primary Cardiovascular Disease Prevention Cohort of People With Human Immunodeficiency Virus on Antiretroviral Therapy

By sjmartinez • October 15, 2022

Looby SE, Kantor A, Burdo TH, Currier JS, Fichtenbaum CJ, Overton ET, Aberg JA, Malvestutto CD, Bloomfield GS, Erlandson KM, Cespedes M, Kallas EG, Masiá M, Thornton AC, Smith MD, Flynn JM, Kileel EM, Fulda E, Fitch KV, Lu MT, Douglas PS, Grinspoon SK, Ribaudo HJ, Zanni MV. Factors Associated With Systemic Immune Activation Indices in a Global Primary Cardiovascular Disease Prevention Cohort of People With Human Immunodeficiency Virus on Antiretroviral Therapy. Clin Infect Dis. 2022 Oct 12;75(8):1324-1333. doi: 10.1093/cid/ciac166. PMID: 35235653; PMCID: PMC9555837.

Tags: cardiovascular disease risk, HIV, immune activation markers, Infectious Diseases, Publications, reproductive aging, Women

MUCOR-ADVANCE: Uniting multidisciplinary science to defeat a deadly fungus

Wurster S, Stewart AG, Gu Y, Youssef EG, John TM, Uppuluri P, Chamilos G, Filler S, Bruno V, Ibrahim AS, Kontoyiannis DP; MUCOR-ADVANCE consortium. MUCOR-ADVANCE:[...]

“We’ll Just Warm Ourselves up with Drugs”: Polysubstance Use among Sexual and Gender Minority Persons (SGMP) Who Inject Drugs in Los Angeles, California

Smeltzer RP, Orta Portillo GA, Ganesh SS, Koerber J, Gould EE, Bolanos R, Gorbach PM, Bluthenthal RN. "We'll Just Warm Ourselves up with Drugs": Polysubstance[...]

Early insights into predicted efficacy of Ebola monoclonal antibodies for the 2026 Bundibugyo virus disease outbreak

Nabukeera KC, Luakanda-Ndelemo G, Semawule S, Ayitewala A, Adroba-Tandele P, Walakira A, Amuri-Aziza A, Jansen D, Galiwango R, Kinganda-Lusamaki E, Tebba A, Ngandu C, Ssemaganda[...]